Nexplanon (Etonorgestrol) implants for contraception
Nexplanon subdermal contraceptive implant for contraception are licenced by the Medicines and Healthcare products Regulatory Authority (MHRA) for up to 5 years of continuous use. This is extended from the previous 3 year guideline.
This extended duration gives patients greater flexibility and reduces the number of times they need to be replaced. Official guidance can be found here:
Nexplanon (etonogestrel) contraceptive implants
Contraceptive implant now licensed for up to 5 years in the UK
